Renaissance Technologies’s Sagimet Biosciences SGMT Stock Holding History

Renaissance Technologies’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.68M	Sell	346,927 -278,542	-45%	-$1.89M	﹤0.01%	1808
2026 Q1	$3.27M	Buy	625,469 +282,969	+83%	+$1.58M	0.01%	1616
2025 Q4	$2.03M	Buy	342,500 +181,100	+112%	+$1.3M	﹤0.01%	1858
2025 Q3	$1.11M	Buy	161,400 +130,500	+422%	+$1.06M	﹤0.01%	2428
2025 Q2	$235K	Buy	+30,900	New	+$130K	﹤0.01%	3125
2025 Q1	–	Sell	-10,800	Closed	-$48.6K	–	3798
2024 Q4	$48.6K	Sell	10,800 -220,300	-95%	-$1.12M	﹤0.01%	3395
2024 Q3	$640K	Sell	231,100 -11,300	-5%	-$34.8K	﹤0.01%	2671
2024 Q2	$829K	Sell	242,400 -177,000	-42%	-$812K	﹤0.01%	2426
2024 Q1	$2.27M	Buy	419,400 +396,400	+1,723%	+$2.85M	﹤0.01%	1948
2023 Q4	$125K	Buy	+23,000	New	+$109K	﹤0.01%	3249

Other funds holding SGMT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Renaissance Technologies's SGMT Position: Q2 2026 in Review

Renaissance Technologies reduced its Sagimet Biosciences (SGMT) stake by 45% in Q2 2026, selling an estimated $1.89M and leaving 346,927 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1808.

Renaissance Technologies first reported a position in SGMT in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.27M in Q1 2026. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

Renaissance Technologies held 346,927 shares of Sagimet Biosciences worth $2.68M as of Q2 2026.
Renaissance Technologies sold 278,542 Sagimet Biosciences shares in Q2 2026, an estimated $1.89M.
Sagimet Biosciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1808 holding.
Renaissance Technologies first reported a position in Sagimet Biosciences in Q4 2023 and has held it in 10 quarters since.
Renaissance Technologies's Sagimet Biosciences position peaked at $3.27M in Q1 2026.
122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.